Akorn Inc. (Nasdaq: AKRX) reported preliminary unaudited financial results for 2015 and expects to file its restated 2014 financials by May 9, 2016. Shares of the generic and branded pharmaceutical leaped $7.36 to $26.08.
Akorn reports preliminary results
March 22, 2016 at 13:05 PM EDT
